Loading your page…
Marketing-authorisation holder
11 medicines in 1 country, as authorisation holder and manufacturer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH RED TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN REGULAR325 mg · Tablet | Paracetamol | Canada | Authorised | |
| ARTHRITIS PAIN RELIEF650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2022 |
| GABAPENTIN CAPSULES400 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES300 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES100 mg · Capsule | Gabapentin | Canada | Authorised | |
| METFORMIN TABLETS850 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| METFORMIN TABLETS500 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| MUSCLE & BODY650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 11 | 11 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
